Tuberculin Skin Tests in Young Children: What Parents Should Know - Pediatrics

More Info

---

Understanding Tuberculin Skin Tests in Young Children: What Parents Should Know
When it comes to assessing the risk of tuberculosis (TB) in young children, the tuberculin skin test (TST), also known as the Mantoux test, is a critical tool. In your case, your two-year-old child had a TST result of 13mm after being in close contact with an individual who has an open case of pulmonary tuberculosis. Given the context of your child's exposure and the test result, it's understandable that you have concerns about the necessity of preventive medication and the implications of the test results.


Interpretation of TST Results
The interpretation of TST results can vary based on several factors, including the child's age, history of exposure to TB, and whether they have received the Bacillus Calmette-Guérin (BCG) vaccine. In general, a TST result of 10mm or more in children who have been in close contact with someone with active TB is considered positive and warrants further evaluation and possibly preventive treatment. Since your child was in close contact with an individual who has TB, the 13mm result is significant.


BCG Vaccination and TST Results
If your child has not received the BCG vaccine, the TST result is more straightforward. However, if they had received the BCG vaccine, it could potentially cause a false-positive result, particularly if the vaccination was administered recently. The BCG vaccine can lead to a positive TST result for several years after vaccination, but the degree of induration (swelling) typically decreases over time. In your case, since your child has a significant induration of 13mm, it is less likely that the BCG vaccine is the sole reason for this result, especially given the recent exposure to an infectious TB case.


External Factors Affecting TST Results
Several external factors can influence the accuracy of the TST. These include the child's overall health, the presence of other infections, and even the technique used to administer the test. The TST is generally considered reliable when performed correctly, but it is not infallible. In some cases, children may have a false-negative result, particularly if they are immunocompromised or have recently been vaccinated with live vaccines.


Preventive Treatment Considerations
Given the positive TST result and the known exposure to an individual with active TB, your child's healthcare provider is likely recommending preventive treatment with isoniazid (INH) for a duration of 9 months. This is a standard approach to prevent the development of active TB disease, especially in young children who are at a higher risk of severe disease if they become infected. While concerns about side effects are valid, the risk of developing active TB, which can have serious health implications, often outweighs the potential risks associated with preventive medication.


Blood Tests as an Alternative
You mentioned considering a blood test for interferon-gamma release assays (IGRAs) as an alternative to the TST. IGRAs can provide additional information about TB infection and are not affected by prior BCG vaccination. However, they are generally more expensive and may not be available in all settings. Discussing this option with your child's healthcare provider can help you make an informed decision.


Conclusion
In summary, your child's TST result of 13mm, in the context of known exposure to an individual with active TB, suggests a significant risk of TB infection. While the BCG vaccine and other external factors can influence TST results, the recommendation for preventive treatment is based on established guidelines to protect your child's health. It is essential to maintain open communication with your healthcare provider to address any concerns and to ensure that your child receives appropriate care.